Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;1(1):58-64.
doi: 10.4161/gmic.1.1.10768.

The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives

Affiliations

The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives

Glen P Carter et al. Gut Microbes. 2010 Jan.

Abstract

Recently, we constructed and characterized isogenic tcdA and tcdB mutants of a virulent Clostridium difficile strain and used a hamster model of disease to demonstrate that toxin B, not toxin A, is essential for virulence of this emerging pathogen. Earlier studies had shown that purified toxin A alone was able to induce C. difficile disease pathology and that purified toxin B was not effective unless it was co-administered with toxin A, suggesting that the toxins act synergistically. In this addendum we discuss this paradigm-shifting conclusion in the context of current strain epidemiology, particularly with respect to naturally occurring toxin A-negative, toxin B-positive isolates and the NAP1/027 epidemic isolates. The role of toxin receptors and how variant toxins might exert their effects is also discussed in relation to the published data. We conclude that it is critical to use the natural infection process to dissect the role of toxins in disease, and that future studies are contingent on such work. The impact and importance of animal models of C. difficile virulence are therefore considered within this frame of reference.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Genetic organization of PaLoc and toxin structure. (A) Genetic organization of PaLoc from C. difficile. XbaI sites (X) are shown, with the PaLoc coordinate indicated, and red ovals show the gene-specific promoters and arrows the direction of transcription. (B) Structural organization of toxin B (toxin A is similar). Coordinates indicate the amino acid number. Relevant domains are shown. Figure modified from ref. .
Figure 2
Figure 2
Mechanism of action of toxin A and toxin B. These toxins glucosylate Rho GTPases, which control many cell signalling pathways, resulting in numerous functional consequences for intoxicated cells. Figure modified from ref. .
Figure 3
Figure 3
Comparative analysis of toxin production by wild-type and toxin mutant C. difficile strains. The wild type is JIR8094 (red bars) and the avirulent strain is CD37, which does not produce toxins. The toxin A mutants are designated as tcdA©1 and tcdA©2 (green bars), the toxin B mutants are tcdB©1 and tcdB©2 (blue bars). Toxin A and toxin B cytotoxicity assays using HT-29 (A) and Vero (B) cells, respectively. Data represent the mean ± s.e.m.; n = 3. Figure modified from ref. .
Figure 4
Figure 4
Kaplan-Meier survival curve demonstrating days from colonization with C. difficile to hamster death. Figure modified from ref. .

Comment on

  • Toxin B is essential for virulence of Clostridium difficile.
    Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, Phumoonna T, Poon R, Adams V, Vedantam G, Johnson S, Gerding DN, Rood JI. Lyras D, et al. Nature. 2009 Apr 30;458(7242):1176-9. doi: 10.1038/nature07822. Epub 2009 Mar 1. Nature. 2009. PMID: 19252482 Free PMC article.

Similar articles

Cited by

References

    1. McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. NEJM. 2005;353:2433–2441. - PubMed
    1. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005;366:1079–1084. - PubMed
    1. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978;75:778–782. - PubMed
    1. Bartlett JG. Antibiotic-associated diarrhea. The New England Journal of Medicine. 2002;346:334–339. - PubMed
    1. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999–2004. Emerging Infectious Diseases. 2007;13:1417–1419. - PMC - PubMed

LinkOut - more resources